CurrentEndo
Get Weekly

Topic · page 32 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 1,241–1,280 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabet Med

    A cohort description and comparison of four European national diabetes registries for the REDDIE project

    Cohort study

  2. JAMA Netw Open

    Cost-Effectiveness of Biomarker-Associated Early Pancreatic Cancer Detection in New-Onset Diabetes

    Cohort study

  3. JAMA Netw Open

    Faith-Based Lifestyle Intervention for Diabetes Prevention Among Adults in Bangladesh: A Cluster Randomized Clinical Trial

    Randomized controlled trial

  4. JAMA Netw Open

    Glucose-Lowering Medication Classes and Cardiovascular Outcomes in Patients With Type 2 Diabetes

    Research article

  5. JAMA Netw Open

    Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 Diabetes

    Research article

  6. JAMA Netw Open

    Social and Behavioral Factors Associated With Diabetes in Southern California vs the US

    Cross-sectional study

  7. Diabetes Care

    Low-Carbohydrate Diets of Varying Macronutrient Quality and Risk of Type 2 Diabetes in Three U.S. Prospective Cohort Studies

    Cohort study

  8. Cardiovasc Diabetol

    An ensemble machine learning-based risk stratification tool for 30-day mortality prediction in critically ill cardiovascular patients

    Cohort study

  9. Cardiovasc Diabetol

    Planetary health diet, other plant-based diets and risk of type 2 diabetes: a prospective study from the UK Biobank

    Cohort study

  10. Cardiovasc Diabetol

    Type 2 diabetes, sodium-glucose cotransporter-2 inhibitors and cardiovascular outcomes: real world evidence versus a randomised clinical trial

    Cohort study

  11. Cardiovasc Diabetol

    Cardiovascular and renal outcomes of dual combination therapies with glucagon-like peptide-1 receptor agonists and sodium-glucose transport protein 2 inhibitors: a systematic review and meta-analysis

    Meta-analysis

  12. Nat Med

    Dietary profiles and associated metabolic risk factors in India from the ICMR–INDIAB survey-21

    Cross-sectional study

  13. Ann Intern Med

    Association Between Body Composition and Cardiometabolic Outcomes : A Prospective Cohort Study

    Cohort study

  14. Diabetes Care

    Undiagnosed G6PD Deficiency in Black and Asian Individuals Is Prevalent and Contributes to Health Inequalities in Type 2 Diabetes Diagnosis and Complications

    Cohort study

  15. Cardiovasc Diabetol

    Accelerated biological aging mediates the associations of stress hyperglycemia ratio (SHR) with mortality in type 2 diabetes and obesity (diabesity)

    Cohort study

  16. Cardiovasc Diabetol

    Association of the triglyceride-glucose index and its combination with obesity indices with cardio-renal-metabolic multimorbidity: two decades of follow-up in the Tehran Lipid and Glucose Study

    Cohort study

  17. Diabetes Obes Metab

    Comparative cardiovascular risk of sulfonylureas with low‐ and high‐affinities for cardiac mitochondrial adenosine triphosphate‐sensitive potassium channels versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: A cohort study

    Cohort study

  18. Diabetes Obes Metab

    Risk of depression with GLP ‐1 receptor agonists use in overweight or obese adults with type 2 diabetes: A new‐user, active‐comparator cohort study

    Cohort study

  19. Nat Med

    Prevention of type 2 diabetes through prediabetes remission without weight loss

    Secondary analysis

  20. Diabetologia

    Complete loss of SLC30A8 in humans improves glucose metabolism and beta cell function

    Research article

  21. Diabetes Res Clin Pract

    Association of the metabolic dysfunction-associated steatotic liver disease with cardiovascular and kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study

    Cross-sectional study

  22. Obesity (Silver Spring)

    Association of BMI and Cognitive Performance in the Diabetes Prevention Program Outcomes Study

    Cohort study

  23. Diabetes Res Clin Pract

    One-hour plasma glucose defining stages of type 2 diabetes − The ELSA-Brasil study

    Cohort study

  24. Diabetes Care

    Development and Internal Validation of the Multiethnic Type 2 Diabetes Outcomes Model for the U.S. (DOMUS)

    Diagnostic or prognostic study

  25. Diabetes Res Clin Pract

    Low Bacteroides abundance is related to endothelial dysfunction in type 2 diabetes

    Cross-sectional study

  26. Cardiovasc Diabetol

    The association between triglyceride-glucose index and all-cause/cardiovascular mortality in patients with different glucose metabolism statuses

    Cohort study

  27. Diabetologia

    Quantitative analysis of human adult pancreatic histology reveals separate fatty and fibrotic phenotypes in type 2 diabetes

    Cross-sectional study

  28. Diabetes Obes Metab

    Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER ‐2 trial emulation with real‐world data

    Cohort study

  29. Diabetes Obes Metab

    Plasma sphingolipids predict advanced liver fibrosis development in patients with type 2 diabetes

    Cohort study

  30. Diabetologia

    Pancreatic cancer-related diabetes and type 2 diabetes differ in multiple aspects of glucose homeostasis

    Cross-sectional study

  31. Diabetologia

    Differences in tissue-specific insulin resistance between South Asian and Nordic women with prediabetes after gestational diabetes

    Cross-sectional study

  32. Diabetes Res Clin Pract

    Clinical outcomes of SGLT2 inhibitors among patients with MASLD and T2DM

    Cohort study

  33. Diabetes Obes Metab

    Genetic evidence for repurposing GLP‐1 receptor agonists in chronic kidney disease and IgA nephropathy: Metabolic and anti‐inflammatory pathways beyond glycaemic control

    Research article

  34. Diabetes Care

    Differences in Prevalence and Incidence of Electrocardiogram Abnormalities and Cardiovascular Autonomic Neuropathy Among Randomized Glucose-Lowering Treatments in Early Type 2 Diabetes: The Glycemia Reduction Approaches in Diabetes (GRADE) Cohort

    Secondary analysis

  35. Cardiovasc Diabetol

    Treatment and associated outcomes of type 2 diabetes mellitus patients with a cardiovascular comorbidity and comparison with guideline recommendations: a German claims data analysis

    Cohort study

  36. Cardiovasc Diabetol

    Fixed-dose vs loose-dose combination antidiabetic therapy and cardiorenal outcomes in type 2 diabetes: a nationwide comparative effectiveness study

    Cohort study

  37. Diabetes Care

    Type 2 Diabetes Remission: A Systematic Review and Meta-analysis of Nonsurgical Randomized Controlled Trials

    Meta-analysis

  38. Diabetes Obes Metab

    Efficacy and safety of Efsubaglutide Alfa in “overrun” patients in the SUPER2 trial: A post‐hoc analysis for comprehensive evaluation

    Secondary analysis

  39. J Diabetes Sci Technol

    Developing a Simple Non–Laboratory-Based Machine Learning Tool for Prediabetes Screening in a Target Population: A Proof-of-Concept Study

    Diagnostic or prognostic study

  40. Diabetes Res Clin Pract

    The miR-200 family in the context of obesity and type 2 diabetes

    Cross-sectional study

All 4,758 Briefs in ExploreShowing Briefs 1,241–1,280 of 4,758, newest first